Multi-institutional randomized phase-3 trial comparing cancer stem cell-targeted vs physician-choice treatments in patients with recurrent high-grade gliomas (NCT03632135). Meeting Abstract (Web of Science)

cited authors

  • Ranjan, Tulika; Sengupta, Soma; Yu, Alexander; Howard, Candace M.; Chen, Ricky; Chaudhary, Rekha; Marko, Nicholas; Aregawi, Dawit; Glantz, Michael; Glass, Jon; Green, Richard M.; Lu-Emerson, Christine; Mammoser, Aaron; Moulding, Hugh; Jubelirer, Steven; Schroeder, Jason; Anderson, Mark; Chow, Frances; Lirette, Seth; Denning, Krista; Alberico, Anthony; Valluri, Jagan; Claudio, Pier Paolo

publication date

  • June 15, 2022


published in



  • 82


  • 12